The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.
Gilead will make an upfront payment of $300m to Dragonfly, with an option for further royalties of up to 20% on global net sales. ... Gilead will gain an exclusive, global licence for DF7001, part of a 5T4-targeting investigational immunotherapy programme
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved a supplemental new drug application for Veklury. ... With the recent opening of our Gilead Pediatric Center of Excellence in Dublin, which is responsible for
New analysis from a phase 3 double-blind, placebo-controlled trial has shown that a three-day course of Gilead’s Veklury significantly decreases the risk of hospitalisation among COVID-19 ... patients. The studies, conducted by Gilead Sciences,
Kite, a Gilead Company, has announced that the US Food and Drug Administration (FDA) has approved the launch of commercial production at its new CAR T-cell therapy manufacturing facility.
As a new supporter of the programme, Gilead Sciences will donate $14m over the next four years. ... BMSF has committed to support 250 Winn Career Development Awards and 250 Winn Pipeline Awards, alongside further backing from Gilead Sciences, pledging
Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...